Concepedia

Hongzhi Lin

HL

Statistics

Publications

7

Citations

310

H-Index

7

Active since

2017

Affiliations

Nanjing University of Chinese Medicine(Current)

China Pharmaceutical University

Hongzhi Lin is an author at Nanjing University of Chinese Medicine specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

2017–2022

7

Publications

7

Discovery of new acetylcholinesterase and butyrylcholinesterase inhibitors through structure-based virtual screening

Yao Chen, Hongzhi Lin, Hongyu Yang et al. · RSC Advances · 2017 · 67 citations · Full text

, , +12

Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease

Jie Zhu, Hongyu Yang, Yao Chen et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2018 · 63 citations · Full text

, , +17

Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors

Jun Mo, Hongyu Yang, Tingkai Chen et al. · Bioorganic Chemistry · 2019 · 53 citations

, , +17

Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease

Yao Chen, Jie Zhu, Jun Mo et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2017 · 36 citations · Full text

, , +17

Investigation of multi-target-directed ligands (MTDLs) with butyrylcholinesterase (BuChE) and indoleamine 2,3-dioxygenase 1 (IDO1) inhibition: The design, synthesis of miconazole analogues targeting Alzheimer’s disease

Xin Lü, Siyu He, Qi Li et al. · Bioorganic & Medicinal Chemistry · 2018 · 35 citations · Full text

, , +17

1–5 of 7